Non-life insurance innovation usually incremental, says Swiss Re
Register for a trial Please sign in to read the full content of this article. If you aren’t already a subscriber, you can register for a free one-month trial.
Insurers must be more innovative
06 December 2011
Published in: Risk management, Investment risk - strategy
Companies: Swiss Re
Sign in
To access the premium content on InsuranceERM, you must first sign in to your account
Aren’t a subscriber? Register for a free one-month trial now.
Highlights
- Solvency II data could cost big insurers over £100m
- Zurich's ERM: setting the tone from the top
- FSA highlights weaknesses in insurers' models
- Majority of insurers lag on Solvency II reporting requirements
- Milliman hires Dunn from KPMG
- Danes keen to enforce 2014 Solvency II deadline
- How Solvency II will affect insurers' bond and equity investments
- Solvency II will hit securitisations but may boost derivatives' use
- Model validation consortium launched
- Compliance costs put financial institutions off overseas ventures
- Further disputes remain likely over matching premiums fudge
- Encoding the directive: XBRL for Solvency II reporting
- Latest Omnibus II text is "confused and overly restrictive"
- Finding the right risk rituals to appease regulators and rating agencies
- Don't underestimate the challenges of workflow, governance and reporting
- Using least squares Monte Carlo for Solvency II proxy modelling
- Looking through concentration risk
- Why cat bonds could shine this year
- Applying complexity science to risk appetite and emerging risk
Copyright © Field Gibson Media Ltd 2012